Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Ocular Surface Disease > IPL therapy outperforms punctal plugs in treating evaporative dry eye, study finds
  • Ocular Surface Disease

IPL therapy outperforms punctal plugs in treating evaporative dry eye, study finds

Ophthalmology 360

Intense pulsed light (IPL) therapy shows superior efficacy in improving the quality of life (QOL) for patients with evaporative dry eye compared to punctal plug insertion, according to a study that found that IPL therapy led to significant improvements in QOL, as measured by the Ocular Surface Disease Index (OSDI) questionnaire, and resulted in increased tear breakup time (TBUT) without any reported complications. In contrast, while punctal plugs also improved QOL for some patients, they were associated with a higher risk of complications.

In the study, patients diagnosed with moderate-to-severe evaporative dry eye completed the questionnaire before and after treatment with IPL therapy (Group 1, n = 15) and silicone punctal plug insertion (Group 2, n = 15).

Results indicated significant improvements in QOL for all patients in Group 1 following IPL therapy, with a decrease in mean OSDI score from 56.9 to 22.9 (P = 0.001). In contrast, Group 2 patients experienced QOL enhancements in 80% of cases, albeit to a lesser extent, with a mean OSDI score dropping from 53.8 to 31.7 (P = 0.017).

IPL therapy demonstrated significant improvements in TBUT within Group 1, increasing from a mean of 3.2 seconds to 5.9 seconds (P = 0.001). Conversely, Group 2 exhibited no significant changes in TBUT values (mean TBUT pretreatment: 3.6 seconds; posttreatment: 3.9 seconds; P = 0.654). Notably, complications such as punctal granuloma and proximal canalicular obstruction occurred in 13.3% of Group 2 patients, while no adverse effects were reported in Group 1.

Reference
Elbakary MA, Shalaby OE, Allam WA, et al. Quality of life improvement in dry eye patients after intense pulsed light therapy compared to punctal plugs. Oman J Ophthalmol. 2024;17(1):108-112. doi: 10.4103/ojo.ojo_85_23. PMID: 38524331; PMCID: PMC10957059.

Share

Related Content

  • Ocular Surface Disease

Scleral lenses improve vision and symptoms across ocular surface diseases

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Neurotrophic Keratitis

Novel anterior keratoplasty approach supports healing in refractory ocular surface disease

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane shows short- and long-term improvements in ocular surface disease

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon